DirexGroup news
"One of the repercussions of COVID-19 is its impact on men`s sexual health. COVID-19 infection is expected to be associated with an increased likelihood of erectile dysfunction (ED). Considering the high transmissibility of COVID-19, ED could be a concerning consequence for a large segment of the population" https://www.ncbi.nim.nih.gov/pmc/articles/PMC8450276/. Coincidentally, DirexGroup introduces MoreNova
The third presentation on the latest treatment approach for Female Sexual Dysfunction (FSD), by Transvaginal Shockwave Therapy (TVST), is to be presented this week at the upcoming European Society of Sexual Medicine. Session PS-01 will be presented by Laszlo Kornya, MD at the upcoming 23rd ESSM Annual Meeting, on Friday, February 18, 2022, at 10:21 AM, in Virtual Room 2 (VR-2). Exhibition this year has gone virtual and will take place on-line only. Dr. Kornya will share his exper
The first of three already conducted clinical pilots, relate to using MoreNova for female Sexual Improvement and Stress Urinary Incontinence. The pilots presented at the International Continence Society (ICS) 2021 Melbourne conference. Treatment was offered to women suffering from stress urinary incontinence, sexual dysfunction or both conditions. Initial results are highly encouraging. Low intensity shockwaves promote angiogenesis, increase nitric oxide release (NO), induc
Vaginal treatment is the latest desirable treatment to be offered by Morenova. Packed as a table-top, compact and lightweight device, MoreNova provides treatment for various ailments and chronic diseases long suffered by women. MoreNova offers multiple applicators, geometrically compatible with various non-medical as well as medical applications. Very encouraging results of treating Stress Urinary Incontinence (SUI) and Female Sexual Dysfunction (FSD) will be presented a
MoreNova Turbo (MT) is a shockwaves device incorporating a compact and powerful energizer, in-line ultrasound localizer and easily interchangeable high-efficiency applicators. The novel applicators are designed to respectively deliver point, linear or planar shockwaves compatible with treating urinary stones, calcified leg arteries, prostate, Chronic Kidney Disease (CKD) and more. Target localization in various patient positions is achieved by motorized and manual applicator’s mo